Medincell SA banner

Medincell SA
PAR:MEDCL

Watchlist Manager
Medincell SA Logo
Medincell SA
PAR:MEDCL
Watchlist
Price: 24.04 EUR -3.61%
Market Cap: €801.7m

Cash Flow Statement

Cash Flow Statement
Medincell SA

Rotate your device to view
Cash Flow Statement
Currency: EUR
Mar-2019 Sep-2019 Mar-2020 Sep-2020 Mar-2021 Sep-2021 Mar-2022 Sep-2022 Mar-2023 Sep-2023 Mar-2024 Sep-2024 Mar-2025 Sep-2025
Operating Cash Flow
Net Income
(20)
(19)
(24)
(26)
(19)
(20)
(25)
(27)
(32)
(26)
(25)
(31)
0
(16)
Depreciation & Amortization
1
1
1
1
1
1
2
2
2
2
2
2
2
2
Stock-Based Compensation
0
0
2
2
2
2
2
2
2
2
3
3
3
3
Other Non-Cash Items
4
3
7
8
5
4
4
7
12
9
8
15
12
13
Cash Interest Paid
2
2
2
2
4
3
1
2
4
5
2
1
2
2
Change in Working Capital
(1)
(3)
4
6
1
(2)
(2)
(2)
(3)
(7)
3
36
24
(12)
Cash from Operating Activities
(16)
N/A
(19)
-17%
(13)
+33%
(10)
+19%
(12)
-20%
(17)
-38%
(21)
-27%
(20)
+6%
(21)
-5%
(23)
-10%
(12)
+48%
22
N/A
19
-10%
(17)
N/A
Investing Cash Flow
Capital Expenditures
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
Other Items
(0)
(0)
1
1
(0)
1
2
1
2
2
1
(6)
(12)
4
Cash from Investing Activities
(1)
N/A
(1)
-5%
0
N/A
0
+11%
(1)
N/A
(0)
+84%
(0)
-86%
(1)
-220%
1
N/A
1
+3%
(1)
N/A
(7)
-1 109%
(13)
-78%
2
N/A
Financing Cash Flow
Net Issuance of Common Stock
23
23
(0)
14
42
28
(0)
(0)
1
24
23
0
40
40
Net Issuance of Debt
8
4
5
9
9
(1)
0
0
5
18
4
(9)
(5)
(5)
Other
(2)
(2)
(2)
(2)
(4)
(3)
(1)
(2)
(4)
(5)
(2)
(1)
(2)
(2)
Cash from Financing Activities
29
N/A
24
-17%
4
-85%
21
+500%
48
+124%
24
-50%
(1)
N/A
(2)
-104%
2
N/A
36
+2 230%
26
-30%
(8)
N/A
33
N/A
33
-1%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
Net Change in Cash
12
N/A
5
-62%
(9)
N/A
11
N/A
35
+206%
7
-80%
(22)
N/A
(23)
-1%
(18)
+20%
15
N/A
13
-11%
6
-56%
40
+588%
18
-54%
Free Cash Flow
Free Cash Flow
(17)
N/A
(19)
-16%
(13)
+31%
(11)
+19%
(13)
-19%
(18)
-39%
(23)
-30%
(22)
+7%
(22)
-1%
(24)
-9%
(13)
+45%
20
N/A
18
-12%
(19)
N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett